<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN" "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
<meta content="text/html; charset=utf-8" http-equiv="Content-Type"/><title>
</title>
<style type="text/css">
			.cs2E86D3A6{text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 0pt}
			.cs5925EB86{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:bold;font-style:normal;}
			.cs95E872D0{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt}
			.csDD5E5F52{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:normal;font-style:normal;}
			.csED7826F6{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:14pt;font-weight:bold;font-style:italic;}
			.csE0B838BE{text-align:justify;text-indent:-86pt;margin:0pt 0pt 0pt 86pt}
			.csA16174BA{color:#000000;background-color:transparent;font-family:Arial;font-size:10pt;font-weight:normal;font-style:normal;}
			.cs9224F58F{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}
			.csC970676{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}
			.cs5ADD8C59{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:9pt;font-weight:normal;font-style:normal;}
			.csE2DB38B2{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:9pt;font-weight:bold;font-style:italic;}
			.cs5D3E032C{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:9pt;font-weight:normal;font-style:normal;text-decoration: line-through;}
			.cs41ED3027{text-align:center;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:12pt;mso-line-height-rule:exactly}
			.csE3E0FE0B{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:normal;font-style:italic;}
			.cs5CA3ADAD{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 54pt;line-height:12pt;mso-line-height-rule:exactly}
			.csD15247B9{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.5}
			.csF0A1D375{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 0pt;line-height:1.5}
			.cs22FF6315{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:bold;font-style:italic;}
			.cs98AF35F2{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:normal;font-style:normal;text-decoration: line-through;}
			.cs2222D344{text-align:center;text-indent:0pt;margin:3pt 0pt 3pt 0pt}
			.csE4480EBF{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:10pt;font-weight:bold;font-style:normal;text-transform:uppercase;}
			.cs2D2816FE{}
			.csD8C6AFB2{width:103.6pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:none;border-right:none;border-bottom:none;border-left:none}
			.cs2CD9A2D1{color:#000000;background-color:transparent;font-family:'Century Schoolbook';font-size:11pt;font-weight:bold;font-style:normal;}
			.cs22DBDE6C{width:193.5pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:none;border-right:none;border-bottom:none;border-left:none}
			.csEAEAF57{width:103.6pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:none;border-right:1pt #000000 solid;border-bottom:none;border-left:none}
			.csF27A2354{width:382.15pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}
			.cs5BCA4A20{width:103.6pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:none;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:none}
			.csA75787F1{width:94.5pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}
			.csF1FDEC69{width:99pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}
			.cs9FFB5A9D{width:89.65pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}
			.cs110AFF96{width:103.6pt;padding:0pt 5.4pt 0pt 5.4pt;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}
			.cs1157FFE2{text-align:right;text-indent:0pt;margin:0pt 0pt 0pt 0pt}
			.cs425D253{width:103.6pt;padding:0pt 5.4pt 0pt 5.4pt;background-color:#D9D9D9;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}
			.csF41A58B4{width:382.15pt;padding:0pt 5.4pt 0pt 5.4pt;background-color:#D9D9D9;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}
			.cs1B16EEB5{color:#000000;background-color:transparent;font-family:Calibri;font-size:11pt;font-weight:normal;font-style:normal;}
			.cs6A0709A4{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 24pt;line-height:1.5}
			.cs9E885863{text-align:justify;text-indent:0pt;margin:0pt 0pt 0pt 18pt;line-height:1.5}
			.cs604CC9C5{width:205.45pt;padding:0pt 1.5pt 0pt 1.5pt;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}
			.cs29689E79{width:69.25pt;padding:0pt 1.5pt 0pt 1.5pt;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}
			.cs43E0282A{width:69.2pt;padding:0pt 1.5pt 0pt 1.5pt;border-top:1pt #000000 solid;border-right:1pt #000000 solid;border-bottom:1pt #000000 solid;border-left:1pt #000000 solid}
			.csF70856CC{text-align:left;text-indent:0pt;margin:0pt 0pt 0pt 18pt}
		</style>
</head>
<body>
<p class="cs2E86D3A6"><span class="cs5925EB86">HB 604-FN - AS INTRODUCED</span></p><p class="cs2E86D3A6"><span class="cs5925EB86"> </span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs2E86D3A6"><span class="csDD5E5F52">2021 SESSION</span></p><p class="cs95E872D0" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	21-0158</span></p><p class="cs95E872D0" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	05/11</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs95E872D0" style="tab-stops:left 108pt;"><span class="csDD5E5F52">HOUSE BILL	</span><span class="csED7826F6">604-FN</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csE0B838BE"><span class="csDD5E5F52">AN ACT	</span><a name="bkTitleDraft0"><span class="csDD5E5F52">expanding the New Hampshire vaccine association to include adult vaccines.</span></a></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csE0B838BE" style="tab-stops:left 86.45pt;"><span class="csDD5E5F52">SPONSORS:	Rep. Knirk, Carr. 3; Rep. Woods, Merr. 23; Rep. Weston, Graf. 8; Rep. Fargo, Straf. 14; Rep. Schapiro, Ches. 16; Sen. Hennessey, Dist 1; Sen. Rosenwald, Dist 13</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csE0B838BE" style="tab-stops:left 86.45pt;"><span class="csDD5E5F52">COMMITTEE:	Health, Human Services and Elderly Affairs</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csDD5E5F52"> </span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csA16174BA">-----------------------------------------------------------------</span></p><p class="cs95E872D0" style="tab-stops:left 90pt;"><span class="csDD5E5F52"> </span></p><p class="cs2E86D3A6"><span class="csDD5E5F52">ANALYSIS</span></p><p class="cs2E86D3A6"><span class="csDD5E5F52"> </span></p><p class="cs9224F58F" style="tab-stops:left 18pt left 86.45pt;"><span class="csDD5E5F52">	This bill expands the New Hampshire vaccine association to include adult vaccines.</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs95E872D0"><span class="csDD5E5F52">- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - </span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">Explanation:	Matter added to current law appears in </span><span class="csE2DB38B2">bold italics.</span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">		Matter removed from current law appears [</span><span class="cs5D3E032C">in brackets and struckthrough.</span><span class="cs5ADD8C59">]</span></p><p class="csC970676" style="tab-stops:left 14.4pt left 82.8pt;"><span class="cs5ADD8C59">		Matter which is either (a) all new or (b) repealed and reenacted appears in regular type.</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	21-0158</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52">	05/11</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52">STATE OF NEW HAMPSHIRE</span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csDD5E5F52"> </span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csE3E0FE0B">In the Year of Our Lord Two Thousand Twenty One</span></p><p class="csC970676" style="tab-stops:left 396pt;"><span class="csDD5E5F52"> </span></p><p class="csE0B838BE"><span class="csDD5E5F52">AN ACT	</span><a name="bkTitleDraft1"><span class="csDD5E5F52">expanding the New Hampshire vaccine association to include adult vaccines.</span></a></p><p class="cs5CA3ADAD" style="tab-stops:left 396pt;"><span class="csDD5E5F52"> </span></p><p class="cs41ED3027" style="tab-stops:left 396pt;"><span class="csE3E0FE0B">Be it Enacted by the Senate and House of Representatives in General Court convened:</span></p><p class="csD15247B9"><span class="csDD5E5F52"> </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt9"></a><span class="csDD5E5F52">1  New Hampshire Vaccine Association; Definitions.  Amend RSA 126-Q:1, III and IV to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		III.  "Assessable lives" means</span><span class="cs22FF6315">:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="cs22FF6315">			(a) </span><span class="csDD5E5F52"> All children under 19 years of age residing in the state who have assessable coverage written or administered by an assessable entity, with the exception of children whose vaccines are paid for under the federal Vaccines for Children program, established under 42 U.S.C. section 1396s. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="cs22FF6315">			(b)  All adults, age 19 through 64, excluding Medicare beneficiaries, residing in the state who have assessable coverage written or administered by an assessable entity.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		IV.  "Assessment" means the assessable entity's liability with respect to [</span><span class="cs98AF35F2">childhood</span><span class="csDD5E5F52">] vaccines determined in accordance with this chapter.  </span><span class="cs22FF6315">Unless preempted by federal law, </span><span class="csDD5E5F52">for purposes of rate setting and medical loss ratio calculations, all association assessments are considered pharmaceutical or medical benefit costs and not regulatory costs.  In the event of any insolvency or similar proceeding affecting any payer, assessments shall be included in the highest priority of obligations to be paid by or on behalf of such payer. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt2"></a><span class="csDD5E5F52">2  New Hampshire Vaccine Association; Definitions.  Amend RSA 126-Q:1, VIII to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		VIII.  "Estimated vaccine cost" means the estimated cost to the state over the course of a state fiscal year of the </span><span class="cs22FF6315">ordering, </span><span class="csDD5E5F52">purchase, distribution, and [</span><span class="cs98AF35F2">administration</span><span class="csDD5E5F52">] </span><span class="cs22FF6315">administrative oversight</span><span class="csDD5E5F52"> of vaccines purchased at the federal discount rate by the department of health and human services. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt3"></a><span class="csDD5E5F52">3  New Hampshire Vaccine Association; Definitions.  Amend RSA 126-Q:1, XI to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		XI.  "Vaccine" means any preparations of killed microorganisms, living attenuated organisms, or living fully virulent organisms that are approved by the federal Food and Drug Administration and recommended by the Advisory Committee on Immunization Practices of the Centers for Disease Control and Prevention and have been authorized by the commissioner of the department of health and human services for administration to children </span><span class="cs22FF6315">and adults </span><span class="csDD5E5F52">of the state of New Hampshire [</span><span class="cs98AF35F2">under the age of 19 years</span><span class="csDD5E5F52">] for the purposes of producing or artificially increasing immunity to particular life-threatening and disabling diseases.  </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt4"></a><span class="csDD5E5F52">4  New Hampshire Vaccine Association; Creation of Association.  Amend RSA 126-Q:2 to read as follows: </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	126-Q:2  Creation of Association.  There is hereby created a nonprofit corporation to be known as the New Hampshire vaccine association.  The association is formed to assess assessable entities for the cost of vaccines provided to certain children </span><span class="cs22FF6315">and adults </span><span class="csDD5E5F52">in New Hampshire. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt5"></a><span class="csDD5E5F52">5  New Hampshire Vaccine Association; Membership, Powers, and Duties of the New Hampshire Association.  Amend RSA 126-Q:3, V(m)-(o) to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(m)  Collect assessments from assessable entities as calculated under RSA 126-Q:4 and deposit said assessments less the association's administrative costs annually and reserves with the state treasurer to the credit of the vaccine purchase fund established pursuant to RSA 141-C:17-a.  At the written request of the association following a majority vote of the board of directors, any funds forwarded to the state treasurer for the vaccine purchase fund remaining unexpended for [</span><span class="cs98AF35F2">childhood</span><span class="csDD5E5F52">] vaccines, shall promptly be returned to the association. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(n)  Be authorized to enter into one or more agreements with other applicable authorities in surrounding states to reduce the risk of duplicate assessments and to assure availability of vaccines for children </span><span class="cs22FF6315">and adults </span><span class="csDD5E5F52">who are residents of this state but who receive vaccination services in other states.  Any costs relating to any such agreement shall be considered additional vaccine costs of the program for purposes of determining the association's assessments. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">			(o)  Adopt procedures by which affiliated assessable entities calculate their assessment on an aggregate basis and procedures to ensure that no assessable life is counted more than once.  Unless otherwise determined by the board, the assessable entity responsible for the payment of the provider's administrative costs for [</span><span class="cs98AF35F2">childhood</span><span class="csDD5E5F52">] vaccines shall be the entity responsible for reporting assessable lives and payment of the corresponding assessment. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt6"></a><span class="csDD5E5F52">6  New Hampshire Vaccine Association; Assessment Determination.  Amend RSA 126-Q:4, I to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		I.  The board shall determine an assessment for each assessable entity in accordance with this section, except that no assessment shall be made based on children excluded from assessable lives whose vaccines are paid for under the federal Vaccines for Children program, established under 42 U.S.C. section 1396s </span><span class="cs22FF6315">or</span><span class="csDD5E5F52"> </span><span class="cs22FF6315">adults whose vaccines are paid for under Medicare. </span><span class="csDD5E5F52"> </span><span class="cs22FF6315">Unless preempted by federal law, </span><span class="csDD5E5F52">an assessment determination made pursuant to this section is a pharmaceutical cost and not a regulatory cost for purposes of calculating the carrier's medical loss ratio </span><span class="cs22FF6315"> </span><span class="csDD5E5F52"> </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt7"></a><span class="csDD5E5F52">7  New Hampshire Vaccine Association; Assessment Determination.  Amend RSA 126-Q:4, V to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">		V.  The board may determine an interim assessment for new vaccines or unanticipated shortfalls in the association's ability to meet [</span><span class="cs98AF35F2">childhood</span><span class="csDD5E5F52">] vaccine funding needs.  The board shall calculate the interim assessment in accordance with paragraph II, and the interim assessment is payable the calendar quarter that begins no less than 30 days following the establishment of the federal contract price.  The board shall not impose more than one interim assessment per year, except in the case of a public health emergency declared in accordance with state or federal law. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="CHAPT"></a><span class="csDD5E5F52">8  New Hampshire Vaccine Association; Immunity from Liability.  Amend RSA 126-Q:8 to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	126-Q:8  Immunity From Liability. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><span class="cs22FF6315">I. </span><span class="csDD5E5F52"> There shall be no liability on the part of and no cause of action of any nature shall arise against any association member or its agents or employees, the association or its agents or employees, members of the board of directors, or the commissioner or the commissioner's representatives, for any action or omission by them in the performance of their powers and duties under this chapter. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><span class="cs22FF6315">II.  There shall be no liability on the part of and no cause of action of any nature shall arise against the state of New Hampshire, including the department of health and human services or its agents or employees, for any action or omission by the state in the performance of its powers and duties under this chapter. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt8"></a><span class="csDD5E5F52">9  New Hampshire Vaccine Association; Vaccine Purchase Fund.  Amend RSA 141-C:17-a to read as follows:</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52">	141-C:17-a  Vaccine Purchase Fund.  There is hereby established a vaccine purchase fund for the </span><span class="cs22FF6315">ordering, </span><span class="csDD5E5F52">purchase</span><span class="cs22FF6315">, distribution, and administrative oversight</span><span class="csDD5E5F52"> of antitoxins, serums, vaccines</span><span class="cs22FF6315">,</span><span class="csDD5E5F52"> and immunizing agents, which are to be provided to the public at no cost except for the actual cost of administering such agents, under RSA 141-C:17.  Any funds provided to the department for this purpose and deposited in the fund shall not be used for any other purpose.  Moneys in the fund shall be continually appropriated to the commissioner of the department of health and human services. </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span><a name="Chapt10"></a><span class="csDD5E5F52">10  Effective Date.  This act shall take effect July 1, 2022.</span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span></p><p class="cs95E872D0" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt left 108pt left 244.8pt;"><a name="bkFiscalNote"><span class="csDD5E5F52">											LBA</span></a></p><p class="cs95E872D0" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt left 108pt left 244.8pt;"><span class="csDD5E5F52">											21-0158</span></p><p class="cs95E872D0" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt left 108pt left 244.8pt;"><span class="csDD5E5F52">											1/13/21</span></p><p class="cs95E872D0"><span class="csDD5E5F52"> </span></p><p class="cs2222D344"><span class="csE4480EBF">HB 604-FN- FISCAL NOTE</span></p><p class="cs2222D344"><span class="csE4480EBF">AS INTRODUCED</span></p><p class="csE0B838BE" style="tab-stops:left 85.5pt;"><span class="csDD5E5F52"> </span></p><p class="csE0B838BE"><span class="csDD5E5F52">AN ACT	</span><a name="bkTitleDraftFN0"><span class="csDD5E5F52">expanding the New Hampshire vaccine association to include adult vaccines.</span></a></p><p class="csD15247B9" style="tab-stops:left 85.5pt;"><span class="cs5925EB86"> </span></p><p class="csD15247B9" style="tab-stops:left 85.5pt;"><span class="cs5925EB86">FISCAL IMPACT:</span><span class="csDD5E5F52">      </span><span class="cs5925EB86">[ X ] State              [    ] County               [    ] Local              [    ] None</span></p><table align="center" border="0" cellpadding="0" cellspacing="0" class="cs2D2816FE" style="border-collapse:collapse;" width="648">
<tr style="height:14.9pt;">
<td class="csD8C6AFB2" width="139"><p class="cs95E872D0"><span class="cs2CD9A2D1"> </span></p></td><td class="cs22DBDE6C" colspan="2" width="258"><p class="cs2E86D3A6"><span class="cs2CD9A2D1"> </span></p></td></tr>
<tr style="height:14.9pt;">
<td class="csEAEAF57" valign="bottom" width="139"><p class="cs95E872D0"><span class="cs2CD9A2D1"> </span></p></td><td class="csF27A2354" colspan="4" width="510"><p class="cs2E86D3A6"><span class="cs2CD9A2D1">Estimated Increase / (Decrease)</span></p></td></tr>
<tr style="height:14.9pt;">
<td class="cs5BCA4A20" width="139"><p class="cs95E872D0"><span class="cs5925EB86">STATE:</span></p></td><td class="csA75787F1" width="126"><p class="cs2E86D3A6"><span class="cs5925EB86">FY 2021</span></p></td><td class="csF1FDEC69" width="132"><p class="cs2E86D3A6"><span class="cs5925EB86">FY 2022</span></p></td><td class="csF1FDEC69" width="132"><p class="cs2E86D3A6"><span class="cs5925EB86">FY 2023</span></p></td><td class="cs9FFB5A9D" width="120"><p class="cs2E86D3A6"><span class="cs5925EB86">FY 2024</span></p></td></tr>
<tr style="height:14.9pt;">
<td class="cs110AFF96" width="139"><p class="cs95E872D0"><span class="cs5925EB86">   Appropriation</span></p></td><td class="csA75787F1" width="126"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td><td class="csF1FDEC69" width="132"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td><td class="csF1FDEC69" width="132"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td><td class="cs9FFB5A9D" width="120"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td></tr>
<tr style="height:14.9pt;">
<td class="cs110AFF96" width="139"><p class="cs95E872D0"><span class="cs5925EB86">   Revenue</span></p></td><td class="csA75787F1" width="126"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td><td class="csF1FDEC69" width="132"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td><td class="csF1FDEC69" width="132"><p class="cs2E86D3A6"><span class="csDD5E5F52">Indeterminable</span></p></td><td class="cs9FFB5A9D" width="120"><p class="cs2E86D3A6"><span class="csDD5E5F52">Indeterminable</span></p></td></tr>
<tr style="height:14.9pt;">
<td class="cs110AFF96" width="139"><p class="cs95E872D0"><span class="cs5925EB86">   Expenditures</span></p></td><td class="csA75787F1" width="126"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td><td class="csF1FDEC69" width="132"><p class="cs1157FFE2"><span class="csDD5E5F52">$0</span></p></td><td class="csF1FDEC69" width="132"><p class="cs2E86D3A6"><span class="csDD5E5F52">Indeterminable Increase</span></p></td><td class="cs9FFB5A9D" width="120"><p class="cs2E86D3A6"><span class="csDD5E5F52">Indeterminable Increase</span></p></td></tr>
<tr style="height:14.9pt;">
<td class="cs425D253" width="139"><p class="cs95E872D0"><span class="cs22FF6315">Funding Source:</span></p></td><td class="csF41A58B4" colspan="4" width="510"><p class="cs95E872D0"><span class="csDD5E5F52">  </span><span class="cs1B16EEB5">[    ] General            [    ] Education            [    ] Highway</span><span class="csDD5E5F52">           </span><span class="cs1B16EEB5">[ X ] Other - Insurance assessments paid to the vaccine purchase fund under RSA 141-C:17-a.</span><span class="cs5925EB86"> </span></p></td></tr>
</table>
<p class="cs6A0709A4"><span class="csDD5E5F52"> </span></p><p class="csF0A1D375"><span class="cs5925EB86">METHODOLOGY:</span></p><p class="cs9E885863"><span class="csDD5E5F52">This bill expands the NH Vaccine Association, which currently purchases vaccines for children under the age of 19, to all adults within the State.  As with the existing children's program, insurance companies would be required to contribute to a vaccine purchasing pool, and would contribute to the program based on the number of assessable lives covered.  Funds raised would be used to support the cost of ordering, purchasing, and distributing vaccines purchased at the federal discount rate by the state Department of Health and Human Services.  For the children's vaccine program currently in place, the Department provides oversight to approximately 250 provider offices throughout the State.  The Department anticipates an additional 350-400 provider offices will be enrolled to handle the additional vaccines provided to adults.  </span></p><p class="cs9E885863"><span class="csDD5E5F52"> </span></p><p class="cs9E885863"><span class="csDD5E5F52">The Department anticipates the bill will result in several million dollars of revenue to the State's dedicated non-lapsing vaccine purchasing fund for the specific purpose of purchasing vaccines and overseeing the program.  The cost of the program will depend on the specific vaccines covered and the take up rate by the adult population.  The Department notes that similar universal adult purchase programs exist in the states of Alaska, Rhode Island, and Vermont, and annual costs in those states range from $2,286,366 (Alaska) to $16,343,632 (Rhode Island).</span></p><p class="cs9E885863"><span class="csDD5E5F52"> </span></p><p class="cs9E885863"><span class="csDD5E5F52">In order to implement the program, the Department assumes it would require four new positions, with costs as follows:   </span></p><table align="center" border="0" cellpadding="0" cellspacing="0" class="cs2D2816FE" style="border-collapse:collapse;">
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs2E86D3A6"><span class="cs5925EB86">FY 2023</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs2E86D3A6"><span class="cs5925EB86">FY 2024</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="cs5925EB86">Program Specialist III (LG 23)</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">Salary</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$47,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$49,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">Benefits</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$29,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$31,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">Other</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$16,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$11,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">     Position Total</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="cs5925EB86">$92,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="cs5925EB86">$91,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="cs5925EB86">Program Specialist IV (LG 25)</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">Salary</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$51,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$53,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">Benefits</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$30,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$32,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">Other</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$9,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$4,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">     Position Total</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="cs5925EB86">$90,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="cs5925EB86">$89,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="cs5925EB86">Technical Support Specialist (LG 23)</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">Salary</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$47,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$49,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">Benefits</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$29,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$31,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">Other</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$9,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$4,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">     Position Total</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="cs5925EB86">$85,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="cs5925EB86">$84,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="cs5925EB86">Nurse Specialist (LG 25)</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">Salary</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$51,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$53,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">Benefits</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$30,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$32,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">Other</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$16,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52">$11,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs95E872D0"><span class="csDD5E5F52">     Position Total</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="cs5925EB86">$97,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="cs5925EB86">$96,000</span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="csDD5E5F52"> </span></p></td></tr>
<tr style="height:14.5pt;">
<td class="cs604CC9C5" valign="top" width="274"><p class="cs1157FFE2"><span class="cs5925EB86">Total Position Costs:</span></p></td><td class="cs29689E79" valign="top" width="93"><p class="cs1157FFE2"><span class="cs5925EB86">$364,000</span></p></td><td class="cs43E0282A" valign="top" width="93"><p class="cs1157FFE2"><span class="cs5925EB86">$360,000</span></p></td></tr>
</table>
<p class="csF70856CC"><span class="cs5925EB86"> </span></p><p class="csF70856CC"><span class="csDD5E5F52">This bill does not contain an appropriation or authorization for the positions.</span></p><p class="cs9E885863"><span class="csDD5E5F52"> </span></p><p class="cs9E885863"><span class="csDD5E5F52">The Insurance Department states that to the extent insurer costs increase above what they are paying for vaccine assessments, premium rates and/or benefit designs may change.  To the extent that premium rates change, the bill will have an indeterminable impact on insurance premium tax revenue. </span></p><p class="cs9E885863"><span class="csDD5E5F52"> </span></p><p class="cs9E885863"><span class="csDD5E5F52">This bill takes effect July 1, 2022.</span></p><p class="cs9E885863"><span class="csDD5E5F52"> </span></p><p class="csF0A1D375"><span class="cs5925EB86">AGENCIES CONTACTED:</span></p><p class="cs9E885863"><span class="csDD5E5F52">Department of Health and Human Services and Insurance Department </span></p><p class="csF0A1D375" style="tab-stops:left 18pt left 36pt left 54pt left 72pt left 90pt;"><span class="csDD5E5F52"> </span></p></body>
</html>
